Top insider buys: Oct 21 – Oct 27, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Oct 21 – Oct 27, 2024.

Week 43, 2024

#	Company	Who bought	Shares	Value	Source
1	IKT Inhibikase Therapeutics, Inc.	3 officers/directors Cluster buy Roberto Bellini, Arvind Kush, Amit Munshi	1,970,000	$2.7M	SEC filings
2	HEI, HEI.A HEICO CORP	10 officers/directors Cluster buy Alan Schriesheim, Victor H. Mendelson, Eric A. Mendelson, Frank J. Schwitter, Adolfo Henriques, Carol F. Fine, Laurans A. Mendelson, Thomas M. Culligan, Mark H. Hildebrandt, Julie Neitzel	7,256	$1.9M	SEC filings
3	NSC NORFOLK SOUTHERN CORP	2 officers/directors Cluster buy Sameh Fahmy, Richard H. Anderson	2,000	$513K	SEC filings
4	TELA TELA Bio, Inc.	2 officers/directors Cluster buy Roberto Cuca, Antony Koblish	153,332	$345K	SEC filings
5	JANX Janux Therapeutics, Inc.	Director RA CAPITAL MANAGEMENT, L.P.	1,200,000	$53.7M	SEC filings
6	PBF PBF Energy Inc.	10% Owner Empresarial De Capitales S.a. De C.v. Control	487,100	$15.5M	SEC filings
7	NRDS NERDWALLET, INC.	2 separate filers Topline Capital Management, LLC, Topline Capital Partners, LP	923,554	$10.6M	SEC filings
8	FPH Five Point Holdings, LLC	Director Sam Levinson	3,283,024	$10.3M	SEC filings
9	TECX Tectonic Therapeutic, Inc.	Director Timothy A. Springer	300,000	$10.1M	SEC filings
10	DYNR DYNARESOURCE INC	2 separate filers Matthew K. Rose, Gareth Nichol	4,273,846	$4.4M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.